Ovarian cancer is the fifth leading cause of death in women in western countries. High-grade serous ovarian cancer (HGSOC) is the predominant subtype of clinical diagnosis, accounting for 70- 80% of ovarian cancer deaths. The focus is now on the early diagnosis of HGSOC. However, a lack of tools to sample the fallopian tubes’ precursor cells remains a major barrier. This project aims to develop a manually or robotically controlled flexible instrument, that will facilitate easy and atraumatic delivery and withdrawal of bio-functional swabs inside the fallopian tubes.